Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin-4 is a filament-forming cytoskeletal GTPase of the septin family, implicated in key cellular processes such as cytokinesis, cytoskeletal organization, and apoptosis[7][2]. It exists in multiple isoforms; notably, the ARTS isoform localizes to mitochondria and distinctively promotes apoptosis by antagonizing XIAP, setting it apart from other septins[1][2]. Septin-4 is required for the formation of the sperm annulus, and thus is essential for male fertility and sperm motility[2][7]. It is also linked to neuronal migration, hematopoietic stem cell regulation, and is expressed predominantly in the brain and heart[2][4]. Disease associations include cancer (via apoptotic regulation), male infertility, and certain neurological conditions[2][6]. No approved drugs are known to directly target Septin-4 as of the latest public datasets.
Induces apoptosis by binding and inhibiting XIAP, leading to caspase activation and cell death. Promotes ubiquitination and degradation of BCL2, enhancing apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin-4 (SEPTIN4).